title: Acquiring orphans.
authors.affiliation: Forbion Capital Partners, Naarden, The Netherlands.
authors.forename: Rogier
authors.initials: R
authors.lastname: Rooswinkel
authors.affiliation: Forbion Capital Partners, Naarden, The Netherlands.
authors.forename: Geert-Jan
authors.initials: GJ
authors.lastname: Mulder
authors.affiliation: 1] Forbion Capital Partners, Naarden, The Netherlands. [2] Leiden University Medical Center, Leiden, The Netherlands.
authors.forename: Sander
authors.initials: S
authors.lastname: van Deventer
mesh_terms: D004345:Drug Industry; D009965:Orphan Drug Production
references.citation: Nat Biotechnol. 2013 Apr;31(4):284-7
references.pmid: 23563416
references.citation: Health Policy. 2010 May;95(2-3):216-28
references.pmid: 20036435
references.citation: Nat Rev Drug Discov. 2013 Feb;12(2):87-90
references.pmid: 23370234
references.citation: Drug Discov Today. 2012 Jul;17(13-14):660-4
references.pmid: 22366309
references.citation: JAMA. 2013 Oct 2;310(13):1343-4
references.pmid: 24084916